(Adds details from paragraph 2 onwards)
March 1 (Reuters) - Australia's Syrah Resources (SYR) said on Friday it will supply natural graphite product from its Balama graphite operations in Mozambique to South Korean chemical and battery material maker Posco Future M 003670.KS .
Under the six-year deal, Syrah will supply up to 2 kilotonnes (kt) of natural graphite per month in the year following commissioning. This can be increased to 5kt per month, with at least six months' notice, from the second year of the deal to the end of term.
The price for the natural graphite supply will be mutually negotiated on a quarterly basis over the term of the agreement, Syrah said.
The deal is part of the graphite producer's strategy to transition Balama natural graphite sales to a more "geographically diversified and commercially aligned customer base", it said.
- Forums
- ASX - By Stock
- SYR
- News: SYR UPDATE 1-Australia's Syrah Resources inks offtake deal with S. Korea's Posco Future M
SYR
syrah resources limited
Add to My Watchlist
1.96%
!
26.0¢

News: SYR UPDATE 1-Australia's Syrah Resources inks offtake deal with S. Korea's Posco Future M
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
26.0¢ |
Change
0.005(1.96%) |
Mkt cap ! $270.9M |
Open | High | Low | Value | Volume |
25.5¢ | 27.3¢ | 25.5¢ | $634.3K | 2.391M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 379430 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 40672 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 370438 | 0.260 |
8 | 196397 | 0.255 |
13 | 317191 | 0.250 |
13 | 503263 | 0.245 |
20 | 837402 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 838 | 1 |
0.270 | 102573 | 1 |
0.275 | 456506 | 8 |
0.280 | 167739 | 5 |
0.285 | 418600 | 6 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SYR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online